Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

Heidelberg Pharma AG, DE000A11QVV0

Heidelberg Pharma AG, DE000A11QVV0

15.09.2021 - 12:06:01

Heidelberg Pharma AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Notification of Major Holdings

1. Details of issuer Name: Heidelberg Pharma AG Street: Gregor-Mendel-Str. 22 Postal code: 68526 City: LadenburgGermany Legal Entity Identifier (LEI): 391200E09XYBYITR1W32 2. Reason for notification ? Acquisition/disposal of shares with voting rights ? Acquisition/disposal of instruments ? Change of breakdown of voting rights X Other reason:voluntary group disclosure relating to treshold contact of a subsidiary 3. Details of person subject to the notification obligation Natural person (first name, surname): Dietmar HoppDate of birth: 26 Apr 1940 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.dievini Hopp BioTech holding GmbH & Co. KGDH-LT-Investments GmbH 5. Date on which threshold was crossed or reached: 13 Sep 2021 6. Total positions ? % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) Total of both in % (7.a. + 7.b.) Total number of voting rights pursuant to Sec. 41 WpHG New 75.32 % 0.00 % 75.32 % 34173009 Previous notification 75.32 % 0.00 % 75.32 % / 7. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG) ISIN Absolute In % ? Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) DE000A11QVV0 171538 25567251 0.50 % 74.82 % Total 25738789 75.32 % b.1. Instruments according to Sec. 38 (1) no. 1 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % 0 0.00 % ? ? Total 0 0.00 % b.2. Instruments according to Sec. 38 (1) no. 2 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % 0 0.00 % ? ? ? Total 0 0.00 % 8. Information in relation to the person subject to the notification obligation? Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more) -Herr Dietmar Hopp % % % -DH-Holding GmbH & Co. KG % % % -DH-Holding Verwaltungs GmbH % % % - % % % -Herr Dietmar Hopp % % % -DHFS II Verwaltungs GmbH % % % -DHFS II Holding GmbH & Co. KG % % % -DH-LT-Investments GmbH 5.69 % % 5.69 % - % % % -Herr Dietmar Hopp % % % -DHFS II Holding GmbH & Co. KG % % % -DH-LT-Investments GmbH 5.69 % % 5.69 % - % % % -Herr Dietmar Hopp % % % -Hopp LT Verm?gensverwaltungs GmbH % % % -DH-Capital GmbH & Co. KG % % % -dievini Hopp BioTech holding GmbH & Co. KG 66.39 % % 66.39 % 9. In case of proxy voting according to Sec. 34 para. 3 WpHG (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting:Proportion of voting rights Proportion of instruments Total of both % % % 10. Other explanatory remarks:? Date14 Sep 2021

15.09.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: Heidelberg Pharma AG Gregor-Mendel-Str. 22 68526 Ladenburg

Germany Internet: www.heidelberg-pharma.com ? End of News DGAP News Service

1233550??15.09.2021?

@ dgap.de